Nabi Biopharmaceuticals and GlaxoSmithKline team up to produce nicotine vaccine and help smokers kick the habit… Anyone who’s ever been a smoker knows just how hard it is to quit. But thanks to a new vaccine that blocks the nicotine in tobacco from entering the brain, quitting could get soon get a lot easier.

Nicotine Vaccine is tested in clinical trials could move on to FDA approval A new vaccine is beginning clinical trials which may help smokers kick their nicotine habit for good. The National Institute on Drug Abuse recently gave Nabi BioPharmaceuticals a $10 million grant to advance NicVAX, the vaccine designed to help people quit smoking, to clinical...